3 results
The primary objective of this study is to evaluate the target engagement of AZD4831, MPO inhibitor by measuring MPO specific activity in plasma following ex vivo stimulation of fresh blood samples with zymosan, in patients with HFpEF. MPO is known…
Primary objective: Assess the efficacy of Phantom Motor Execution (PME) aided by Myoelectric Pattern Recognition (MPR), Augmented and Virtual Reality (AR-VR), and Serious Gaming (SG) to reduce Phantom Limb Pain (PLP). Secondary objective: Assess the…
This study aims to evaluate the effect of AZD4831 on functional improvement and reduction of symptoms in participants with heart failure with left ventricular ejection fraction > 40%. Additionally, the PK and overall safety profile of AZD4831…